{"type":"PR","pr":{"number":20,"head":"9e98c565417aecb1c5353c6c50ca814984d19b93"},"user":"silvia.vernotico","status":"pending_publish","branch":"cms/2018-08-25-hot-this-week-in-farmaceutica-younger-n-64","collection":"hotthisweek","title":"HOT THIS WEEK IN FARMACEUTICA YOUNGER N.64","description":"La Food and Drug Administration (FDA) statunitense ha approvato Onpattroâ„¢ (patisiran), la prima terapia basata sull'RNA interference (RNAi). ","objects":{"entry":{"path":"site/content/hotthisweek/2018-08-25-hot-this-week-in-farmaceutica-younger-n-64.md","sha":"690576f948241129a698dd2638b1cb0f68c58edf"},"files":[{"path":"/site/static/img/img_3180-2.jpg","sha":"9defda7ecd9d4e761e04613df7e811f0ccfdedfc"}]},"timeStamp":"2018-08-25T21:54:12.901Z"}